search buttonmobile navigation expand button

Need Assistance?

Back to Search Results

RTOG 0924

RTOG 0924, Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial.
The purpose of this study is to compare the effects of hormone therapy (androgen deprivation) and radiation therapy to the prostate gland and seminal vesicles with hormone therapy and radiation therapy to the whole pelvic body area on prostate cancer to find out which is better.
Trial Information
Principal Investigator: Dr. Kiran Devisetty

Contact: MCI: McLaren Center for Research & Innovation:(248) 484-4960

IRB Number: MCI:2012-00084 01368588

More Information: